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Abstract
Purpose Shunt infection is a major problem in paediatric neurosurgery. Our institution introduced a mandatory shunt protocol
with the aim of reducing infection rate.
Methods A retrospective cohort study including consecutive patients undergoing permanent shunt operations (primary insertion
and revision) across two study periods: 3 years immediately prior (2009–2012) and 3 years immediately after (2012–2015)
protocol introduction. Absolute and relative risk reductions (ARR/RRR) and Chi-square statistical analysis was used alongside
logistic regression, where any single factor with p ≤ 0.20 included in the multivariate model, producing an odds ratio (OR).
Results Eight hundred nine operations in 504 children were identified (442 pre-protocol, 367 post). Overall infection rate
decreased from 5.43% (24/442) pre-protocol to 3.27% (12/367) post-protocol (ARR = 2.16%, RRR = 39.8%, NNT = 46.3, p =
0.138), which did not reach statistical significance. For primary shunt insertions, infection rate reduced from 3.63 to 2.55%
(ARR = 1.08%, RRR = 29.8%, NNT = 92.6, p = 0.565), whilst for revisions, it reduced from 6.83 to 3.81% (ARR = 3.02%, RRR
44.2%, NNT = 33.1, p = 0.156). Multivariate logistic regression showed that surgeon experience was a statistically significant
predictor of infection, whilst responsible pathogens and latency were similar across the pre- and post-protocol groups.
Conclusion The protocol reduced overall infection rate in primary and revision shunt operations and we recommend paediatric
units consider introducing a similar protocol for these procedures.
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Introduction
Implanted CSF shunts are used extensively in the manage-
ment of hydrocephalus, and shunt-associated infection is a
major source of morbidity in paediatric neurosurgical practice
[1]. Single-centre shunt infection rates range between 6 and
15% [2, 3]. A recent multi-centre study, which included 1036
patients from 6 centres in the USA, reported an overall shunt
surgery infection rate of 11% [4].
Shunt infection is associated with considerable mortality
and morbidity. Infection-related mortality has been reported
to range from 1.5 to 22% [2], with those surviving facing the
risk of significant morbidities such as permanent neurological
deficit, cognitive impairment, and epilepsy [5]. Shunt infec-
tions are treated with intravenous and intra-ventricular antibi-
otics, which come with associated side effects, lengthy hospi-
tal stays, and the need for additional surgical procedures [6].
These serious implications, coupled with the fact that shunt
operations are the most common paediatric neurosurgical pro-
cedure performed, have made targeting and minimising shunt
infections a key concern. Recent literature produced by the
Hydrocephalus Clinical Research Network has suggested that
the development and implementation of a standardised, step-
wise protocol governing paediatric shunt procedures can have
a significant effect on shunt infection rates [7, 8].
Motivated by this important work, we developed a compre-
hensive and mandatory Bshunt protocol^ for our institution,
with guidance on pre-, intra-, and post-operative surgical and
nursing management, with the aim of reducing shunt surgery-
associated infections. We report our experience and early
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results following introduction of this protocol, by comparing




Using our institution’s computerised prospective neurosurgi-
cal database that maintains details of patients’ demographics,
operative details, and complications, we identified all patients
who underwent a permanent ventriculoperitoneal,
ventriculoatrial, or ventriculopleural shunt procedure within
our study period. The protocol was introduced on the 1st of
July 2012, which was used as the cut-off point to produce two
cohorts containing consecutive cases, one cohort including all
relevant shunt procedures 3 years immediately prior to this date
(1st July 2009–31st June 2012) and the other cohort including
those 3 years immediately after (1st July 2012–31st June
2015). Procedures were also subdivided into primary insertion
and shunt revisions. BPrimary insertion^ was defined as inser-
tion of a shunt into a child with no pre-existing CSF diversion
hardware—either externalised drains or shunt. VP shunt inser-
tions in children who had undergone previous non-CSF shunt
surgeries, such as endoscopic third ventriculostomies or CNS
tumour resections, were included in this category. BRevision^
was defined as any surgery on a child with a pre-existing,
internal CSF shunt whereby one or more (including all) of
the components of the shunt were changed, but that the child
continued to have a permanent, internalised shunt at the end of
the procedure (i.e. shunt removals and externalisations were
not included in the analysis). We excluded patients having
Binternalisation^ procedures (i.e. insertion of shunt hardware
at the same operation of removal of external drainage systems).
Infections were identified using the complications contem-
poraneously recorded on the neurosurgical database, and con-
firmed by interrogation of case notes and our separate pathol-
ogy database. The minimum follow-up was 12 months post-
surgery. The following criteria were used to define CSF shunt
infection: CSFmicroscopy or culture that yielded an organism
or CSF pleocytosis associated with fever, shunt malfunction,
or neurological symptoms that required shunt removal and
subsequent antimicrobial treatment. Superficial incisional or
deep incisional infections that did not require shunt removal
were not classed as CSF shunt infection.
Shunt protocol
A multidisciplinary team in our institution, including consul-
tant neurosurgeons, microbiologists, and specialist nurses pro-
duced and reviewed the stepwise protocol using a combina-
tion of relevant literature and collective clinical experience [7,
9–12]. The protocol identified factors relevant to the four
phases of each procedure, i.e. pre-operative, intra-operative,
post-operative, and pre-discharge factors.
Pre-operative care factors designed to reduce infection rate
include a chlorhexidine bath and hair wash, ensuring patients
have short, clean nails with no nail varnish and are dressed in
appropriate theatre gowns with cotton underwear (Fig. 1).
Intra-operative care included guidelines on number of persons
in theatre, hair clipping, site preparation, draping, intra-
operative technique, wound closure and dressings, as well as
intra-operative antibiotics and patient warming (Fig. 2). Post-
operative and pre-discharge factors focused on washing,
wound care, and antibiotic administration (Figs. 3 and 4).
Compliance at all four stages was monitored with check-
lists provided to ward and operating room nursing staff. All
children admitted for shunt surgery have these checklists au-
tomatically added to their clinical notes.
Statistical analysis
Pearson chi-square test and two-tailed T test were used to com-
pare study group characteristics and infection rate before and
after the introduction of the protocol, with further subgroup
analysis comparing the effect of protocol introduction on pri-
mary and revision procedures. Univariate binary logistic regres-
sionwas used to investigate for an association between infection
and the following factors: age at procedure, gender of patient,
type of procedure, use of protocol, grade of operating surgeon,
nature of operation (emergency or routine), and presenting di-
agnosis. Any factor with at least a weak association (p ≤ 0.2)
was then included in the multivariate logistic regression model.
The effect of the protocol and age at procedure were then forced
into the model. Age was included due to the established asso-
ciation between young age and shunt infection in literature [1,
13, 14]. Latency between date of procedure and infection diag-
nosis and cultured organism data was recorded in order to iden-
tify the most common pathogens and to note any variation in
frequency or latency between the pre and post-protocol groups.
Statistical analysis was carried using Microsoft Excel
(Microsoft, Inc.) and SPSS statistical software (SPSS, Inc.).
Results
Study group characteristics
Eight hundred nine procedures performed in 504 patients
matched our inclusion criteria, with 442 procedures in the
pre-protocol cohort and 367 in the post-protocol cohort.
Population demographics are tabulated in Table 1. There were
no statistically significant differences noted between the two
cohorts in terms of age at procedure, gender, type of proce-
dure, or grade of operating surgeon.
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Generally, there was good equivalence between the two
cohorts in terms of aetiology, with no statistically significant
differences noted. The most frequently identified aetiology
was post-haemorrhagic hydrocephalus, representing 23.5%
of all patients, followed by tumour-induced hydrocephalus
making up 15.2% of patients (Fig. 5).
Shunt infection rate
A total of 36 shunt infections in 809 procedures were identi-
fied across the study period, i.e. 4.45% of all shunt procedures
identified. In the primary shunt insertion subgroup, there were
11/350 infections (3.14%), whilst in the shunt revision sub-
group, there were 25/459 infections (5.45%).
The overall infection rate decreased after the introduction
of the protocol from 24 in 442 (5.43%) to 12 in 367 (3.27%),
an absolute risk reduction (ARR) of 2.16%, with a relative risk
reduction of 39.8% and the number needed to treat (NNT) to
prevent one infection of 46.3 (Table 2, Fig. 6). However, chi-
square analysis did not reach significance (p = 0.138).
For primary shunt insertions, the NNT was 92.6 (ARR =
1.08%, RRR = 29.8%), with chi-square analysis again not
showing statistical significance (p = 0.565). The largest effect
was observed in the shunt revision subgroup, where the NNT
was 33.1 (ARR = 3.02%, RRR = 44.2%, p = 0.156).
Regression analysis
No factor analysed using univariate binary regression against
shunt infection showed an association (at the P ≤ 0.2 level)
except for procedure subtype (primary or revision; p = 0.120),
Fig. 1 Pre-operative protocol
check list
Fig. 3 Discharge protocol check listFig. 2 Post-operative protocol check list
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Fig. 4 Intra-operative protocol check list
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grade of operating surgeon (p = 0.016), and use of protocol
(p = 0.142).
These were used in the multivariate model (Table 3) along
with age at procedure. Age (p = 0.668) was included in the
model despite not meeting this requirement due to the
established association between low age and infection risk in
literature. The surgeon grade was the only factor shown to be
significantly associated with reduced risk of infection in this
model (p = 0.028). Regression analysis showed an odds ratio
of 0.581 in the post-protocol group compared to the pre-
protocol group (p = 0.245), when adjusting for the other fac-
tors included in the analysis.






Number of procedures 809 442 367
Mean age in months ± SD 55.8 ± 62.8 59.4 ± 63.7 49.8 ± 60.4
Gender
Male 435 (53.8%) 225 (50.9%) 210 (57.2%)
Female 374 (46.2%) 217 (49.1%) 157 (42.8%)
Procedure type
Primary shunt insertion 350 (43.3%) 193 (43.7%) 157 (42.8%)
Shunt revision 459 (56.7%) 249 (56.3%) 210 (57.2%)
Diagnosis
Tumour 123 (15.2%) 72 (16.3%) 65 (13.9%)
Post-IVH 190 (23.5%) 84 (19.0%) 106 (28.9%)
Spina bifida 78 (9.6%) 38 (8.6%) 40 (10.9%)
Craniofacial or craniocervical 57 (7%) 35 (7.9%) 22 (6.0%)
IIH 38 (4.7%) 26 (5.9%) 12 (3.3%)
Post-infection 38 (4.7%) 20 (4.5%) 18 (4.9%)
Aqueduct stenosis 27 (3.3%) 16 (3.6%) 11 (3.0%)
Vascular disorder 13 (1.6%) 8 (1.8%) 5 (1.4%)
Trauma 8 (1.0%) 6 (1.4%) 2 (0.5%)
Epilepsy 1 (0.1%) 1 (0.2%) 0 (0.0%)
Other 236 (29.2%) 136 (30.8%) 100 (27.2%)
Grade of operating surgeon
Consultant 496 (61.3%) 271 (61.3%) 225 (61.3%)
Resident/fellow 313 (38.7%) 171 (38.7%) 142 (38.7%)
Fig. 5 Breakdown of hydrocephalus aetiology in both cohorts
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Compliance data
Compliance to the protocol was variable, with a range of 56%
during the first month of introduction to 100% once it was
established. Overall, 60% of the protocol checklists were
returned. Of those, there was an average of 88% compliance.
Compliance data was available for 10 of the 12 infection cases
after the introduction of the protocol. There was only 1 docu-
mented protocol breach in a case that led to infection, which
was incorrect prophylactic antibiotic administration in a pa-
tient in whom pre-operative screening skin and mucosa swabs
had indicated methicillin-resistant Staphylococcus aureus
(MRSA) carriage and antibiotic choice was not amended to
account for this. Hence, there was no statistical association
between protocol breaches and infection.
Cultured organisms and latency
Of the 36 infections identified, 34 cultured a pathogenic or-
ganism with two patients treated empirically based on criteria
discussed in the methods. CSF samples were the source of 27
of these cultured cases, with wound samples representing a
further 7. The most commonly cultured organism was
Staphylococcus aureus (Fig. 7, n = 17), followed by
coagulase-negative staphylococci (n = 9).
This pattern was again seen in both the pre-protocol and
post-protocol cohorts, although Enterococcus faecalis equalled
coagulase-negative staphylococcus as the second most com-
mon cultured organism in the post-protocol group (n = 2).
In terms of latency, the average length of time between the
date of the procedure and diagnosis of infectionwas 54.8 days.
The pre-protocol group had an average latency of 67.3 days,
compared to the post-protocol average of 29.9 days. However,
two-tailed independent t test analysis did not demonstrate this
difference to be statistically significant (p = 0.421).
Discussion
The overall effect of the protocol in reducing the infection rate
was similar to that seen in the literature [1, 7]. However, this
reduction did not achieve statistical significance, which may
Table 2 Infection rates before
and after introduction of protocol,











Total 24/442 (5.43%) 12/367 (3.27%) 0.602 0.31 to 1.19
Primary 7/193 (3.63%) 4/157 (2.55%) 0.702 0.21 to 2.36
Revision 17/249 (6.83%) 8/210 (3.81%) 0.558 0.25 to 1.27
Fig. 6 Overall CSF shunt
infection rate: before (shaded bar)
and after (open bar) introduction
of protocol, in all cases (left),
primary insertions only (centre),
and revisional cases (right)
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be due to the contribution of a number of factors. Our institu-
tion’s infection rate was relatively low in the pre-protocol
cohort to begin with, thereby requiring a large number of
patients to achieve significance. In fact, the initial control in-
fection rate demonstrated by the HCRN of 8.8% was reduced
to 5.7% after the introduction of their protocol [8], which is
0.3% greater from our initial pre-protocol group’s 5.4% infec-
tion rate. Continuous review of the effects of the protocol as
the number of procedures after the introduction of the protocol
increases could yield significance.
There was a difference between the average ages between the
pre- and post-protocol cohorts, which was not found to be statis-
tically significant. Although this association was not demonstrat-
ed in our analysis at a statistically significant level (p = 0.745),
young age is an established risk factor for infection [1, 13–15]
and thus may have worked against the beneficial effect of the
protocol. A relatively large differencewas also noted between the
proportion of patients in the post-protocol group with post-IVH
as their presenting diagnosis compared to the pre-protocol group
(18.0% compared to 28.6%), another factor described in litera-
ture as associated with infection [15], although this difference
was not quite statistically significant (p = 0.06). Univariate re-
gression analysis also did not show an association between in-
fection and presenting diagnosis (p> 0.2).
Whilst the reduction did not reach statistical significance, the
reduction in infection rate in both the primary and revision
groups was encouraging—with NNTs of 92.6 (primary) and
33.1 (revisions)—suggesting that major units performing large
numbers of such surgeries would see benefits from introducing
similar protocols. With the large cost—both clinically and finan-
cially—of shunt infections, and a relatively simple and benign
intervention of introducing a protocol, preventing 1 infection per
46.3 surgeries would appear to be a desirable effect.
Suboptimal compliance with the protocol may have had an
effect on infection rate. A higher checklist return rate (60%)
would allow investigation for associations between infection
and individual components of the protocol. Care must be tak-
en to improve checklist return and allow enhanced evaluation
of the protocol.
Although the overall shunt infection rate is comparable, or
even favourable, with the majority of large series in the liter-
ature, it is notable that it is still higher than the negligible rates
Table 3 Table demonstrating
results of multivariate logistic
regression. Odds ratios given are
in comparison to baseline factor
Factor Odds ratio (95% confidence interval) Significance (p value)
Use of protocol 0.581 (0.285–1.184) 0.135
Surgeon grade (consultant vs. Res/Fell) 0.462 (0.232–0921) 0.028
Type of procedure
Revision 1
Primary 0.613 (0.283–1.330) 0.216
Age at procedure 0.999 (0.993–1.005) 0.745
Fig. 7 Causative pathogenic organisms in CSF shunt infections, before (shaded bar) and after (open bar) introduction on protocol
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achieved in two landmark series, from Paris [16] and Belgium
[9]. In these series, all shunt surgeries were carried out on
elective lists by a single senior surgeon. In the current series,
operations were performed by a number of different surgeons
at attending/consultant, fellow, and resident grades, with some
cases being performed as ad hoc emergencies and some on
planned elective lists. Surgeon seniority was a risk factor in
the regression analysis of the current study, supporting the
contention that the excellent rates achieved in the two cited
studies depend on senior surgeon input. Differing health sys-
tems and clinical workloads internationally may affect the
ability of individual institutions to achieve senior input for
all shunt cases but we agree it is an ideal to strive towards.
Using this data, it may be possible to begin collaboration
between different paediatric neurosurgical units to develop
and implement a standardised protocol and establish a com-
mon baseline. This would benefit from a significantly larger
sample size and hence allow more rapid analysis of the bene-
fits, permitting adjustment where needed.
Conclusion
Although the reduction in infection rates after the introduction of
this protocol did not reach statistical significance, the reduction in
overall infection rate in primary and revision shunt operations is
highly promising, considering our initially low baseline infection
rate. We recommend paediatric neurosurgical units consider in-
troducing similar protocols for these procedures.
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